Neogenomics, Inc. · NASDAQ:NEO

Kanovsky Stephen M exercised options for 23,077 Neogenomics, Inc. shares (Form 4)

Traded Jun 1, 2026 · Filed Jun 3, 2026

On Jun 1, 2026, Kanovsky Stephen M (Director) exercised options for 23,077 Neogenomics, Inc. shares, leaving 75,421 shares. Filed Jun 3, 2026 (Form 4).

Options exercised
23,077 shares
Holding after
75,421 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 1, 2026Common StockOption exercise23,07775,421Direct

Source

View original at SEC

Related